Design and synthesis of novel benzoheterocyclic derivatives as human acrosin inhibitors by scaffold hopping

Eur J Med Chem. 2013 Jan:59:176-82. doi: 10.1016/j.ejmech.2012.11.005. Epub 2012 Nov 17.

Abstract

Human acrosin is an attracting target for the development of novel male contraceptives. Scaffold hopping was used to optimize the isoxazolecarbaldehyde human acrosin inhibitors and extend their structure-activity relationships. Four kinds of scaffolds, namely benzimidazole, benzothiazole, 3H-indazole, and 5-phenyl-1H-pyrazole, were designed and synthesized. Most of the synthesized compounds showed potent human acrosin inhibitory activity and their binding modes were investigated by molecular docking. The scaffold of the compounds was found to be important for the inhibitory activity. Several compounds were more active than the positive control TLCK, suggesting that they can serve as good starting points for the discovery of novel male contraceptive agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrosin / antagonists & inhibitors*
  • Benzimidazoles / chemistry
  • Binding Sites
  • Drug Design*
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Heterocyclic Compounds / chemical synthesis*
  • Heterocyclic Compounds / chemistry
  • Heterocyclic Compounds / pharmacology
  • Humans
  • Male
  • Molecular Docking Simulation
  • Molecular Structure

Substances

  • Benzimidazoles
  • Enzyme Inhibitors
  • Heterocyclic Compounds
  • benzimidazole
  • Acrosin